| Name | Saikosaponin B1 |
|---|---|
| Synonyms |
Saikosaponin B1, 10 mM in DMSO
SAIKOSAPONIN B1 (2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5S,6R)-3,5-Dihydroxy-2-(((3S,4R,4,6,6bS,8S,8aS,14,14bS)-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,14a,14b-octadecahydropicen-3-yl)oxy)-6-methyltetrahydro-2H-pyran-4-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol Saikosaponin B pns25 SAG Antifoam (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,4R,4,6,6bS,8S,8aS,14,14bS)-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicen-3-yl]oxy]-3,5-dihydroxy-6-methyloxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol (3β,16β)-16,23,28-Trihydroxyoleana-11,13(18)-dien-3-yl 6-deoxy-3-O-β-D-glucopyranosyl-β-D-galactopyranoside KS66 Saikosaponin b1 Standd pdms (3b,4a,16b)-16,23,28-trihydroxyoleana-11,13-dien-3-yl-6-deoxy-3-o-beta-d-glucopyranosyl-beta-d-galactopyranoside HMDO pms1.5 SaikosaponinB Saikosaponin B1-RM sf-96 [(4R)-16β,23,28-Trihydroxyoleana-11,13-dien-3β-yl]3-O-(β-D-glucopyranosyl)-6-deoxy-β-D-galactopyranoside SaikosaponinB1 ko08 Sailkosaponins b1 |
| Description | Saikosaponin B1 is a component of Saiko, enhances the effect of cancer chemotherapy[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 909.9±65.0 °C at 760 mmHg |
| Melting Point | 235-238ºC |
| Molecular Formula | C42H68O13 |
| Molecular Weight | 780.982 |
| Flash Point | 504.1±34.3 °C |
| Exact Mass | 780.466003 |
| PSA | 218.99000 |
| LogP | 3.59 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.619 |
| Storage condition | 2-8°C |
|
~%
58558-08-0 |
| Literature: Chemical and Pharmaceutical Bulletin, , vol. 33, # 8 p. 3349 - 3355 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |